Kronos Worldwide, Inc.
American titanium dioxide (TiO2) manufacturer (NYSE: KRO, HQ Dallas TX; Contran Corporation/Harold Simmons family ~85% ownership; ~$1.8B revenue); operates TiO2 plants in the US (Savannah GA, Hamilton Mississippi), Germany (Leverkusen, Uerdingen), Belgium (Langerbrugge), and Norway (Fredrikstad) using the sulfate process. The sulfate process for TiO2 production generates large volumes of ferrous sulfate (FeSO4·7H2O, 'copperas') as an unavoidable byproduct — for every tonne of TiO2 produced via sulfate process, approximately 4-6 tonnes of ferrous sulfate are generated. Kronos purifies and sells food-grade ferrous sulfate to pharmaceutical and infant formula manufacturers. This creates a remarkable supply chain relationship: the iron supplement in infant formula is a byproduct of making white paint pigment (TiO2 is the primary white pigment in all white paints). When Kronos's TiO2 production is curtailed (construction downturn, housing slump), ferrous sulfate supply to infant formula manufacturers falls in lockstep, regardless of infant formula demand. TiO2 and infant iron nutrition share the same production bottleneck.